STARD8 Antikörper (AA 1-1023)
Kurzübersicht für STARD8 Antikörper (AA 1-1023) (ABIN2367394)
Target
Alle STARD8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-1023
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- STARD8 (START Domain-containing Protein 8, StARD8, StAR-related Lipid Transfer Protein 8, ARHGAP38, Deleted in Liver Cancer 3 Protein, DLC3, DLC-3, KIAA0189, STARTGAP3, START-GAP3)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- Full length human STARD8, aa1-1023 (NP_055540.2).
-
Isotyp
- IgG
-
-
anti-StAR-Related Lipid Transfer (START) Domain Containing 8 (STARD8) (AA 181-230) antibody
STARD8 Reaktivität: Human, Hund, Affe, Fledermaus WB Wirt: Kaninchen Polyclonal unconjugated
anti-StAR-Related Lipid Transfer (START) Domain Containing 8 (STARD8) (AA 220-255) antibodySTARD8 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB54160 unconjugated
anti-StAR-Related Lipid Transfer (START) Domain Containing 8 (STARD8) (AA 1-1023) antibodySTARD8 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-StAR-Related Lipid Transfer (START) Domain Containing 8 (STARD8) (AA 201-250) antibodySTARD8 Reaktivität: Human, Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-StAR-Related Lipid Transfer (START) Domain Containing 8 (STARD8) (N-Term) antibodySTARD8 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- STARD8 (StAR-Related Lipid Transfer (START) Domain Containing 8 (STARD8))
-
Andere Bezeichnung
- STARD8
-
NCBI Accession
- NM_014725
Target
-
